Hovione creates new company to sell devices

Hovione has announced the launch of a new company called Hovione Technology, which “focuses on offering an inhaler that matches your product, your needs, your patients.” The company’s devices include the Twin Caps and PowdAir capsule-based dry powder inhalers.

According to an email from the company, Hovione Technology is “a Hovione Ventures company”; both companies were registered in Ireland on May 18, 2016, with Peter Villax listed as CEO and João Ventura, who joined Hovione in 2014, named Business Development Manager for Hovione Technology.

Share

published on

Featured event:

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA

September 24-September 25Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK